Overview
Benign pheochromocytoma refers to non-malignant adrenal tumors that typically secrete catecholamines, leading to symptoms such as hypertension and episodic headaches. Unlike malignant forms, benign pheochromocytomas generally do not metastasize and can often be managed effectively with surgical intervention 1.Diagnosis
Clinical Presentation: Hypertension, episodic headaches, palpitations, and sweating 1.
Biochemical Testing: Elevated plasma free metanephrines and normetanephrines 1.
Imaging: CT or MRI to localize the tumor; MIBG scintigraphy can also be useful 1.
Genetic Testing: Consider in familial cases to identify syndromes like multiple endocrine neoplasia type 2 (MEN2) 1.Management
Surgical Resection: Primary treatment, typically laparoscopic adrenalectomy 1.
Preoperative Alpha-Blockade: Use alpha-adrenergic blockers (e.g., phenoxybenzamine) to control hypertension before surgery 1.
Postoperative Monitoring: Close monitoring for persistent hypertension or recurrence 1.Special Populations
Pediatrics: Increased caution with radiation therapy due to higher risk of malignant transformation and new tumor induction 1.
Comorbidities: Management strategies similar, but individualized care plans are essential, especially for those with complex medical histories 1.Key Recommendations
Surgical intervention is the mainstay of treatment for benign pheochromocytoma (Evidence: Strong 1).
Preoperative alpha-adrenergic blockade is crucial to manage hypertension before surgery (Evidence: Strong 1).
Exercise caution with radiation therapy in pediatric patients and those with tumor predisposition syndromes (Evidence: Moderate 1).References
1 Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. Journal of medical genetics 2006. link
2 Jessee EF, Owen DS, Sagar KB. The benign hypermobile joint syndrome. Arthritis and rheumatism 1980. link